HC Wainwright Initiates OncoMed Pharmaceuticals With Buy Rating, $20 Target
September 22, 2016 at 10:45 AM EDT
HC Wainwright has started coverage of Oncomed Pharmaceuticals Inc (NASDAQ: OMED) shares with a Buy rating. The firm sees 68 percent ...